GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71−0.33 (-16.42%)
Close on Nov 13, 2026Market cap $717.73KP/E –Yield –
GeoVax Labs enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
GeoVax Labs's enterprise value was $12.77M on Nov 11, 2026, against $300.29M a year earlier. Over the last 5 years it ranged from -$681.36K to $232.12B, with a median of $9.74B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.77M | -89.5% |
| 2025 | Dec 31, 2025 | $121.98M | -99.0% |
| 2024 | Dec 31, 2024 | $12.75B | -85.3% |
| 2023 | Dec 29, 2023 | $86.71B | -41.9% |
| 2022 | Dec 30, 2022 | $149.31B | -28.2% |
| 2021 | Dec 31, 2021 | $207.87B | +92.0% |
| 2020 | Dec 31, 2020 | $108.25B | +148053.9% |
| 2019 | Sep 30, 2019 | $73.07M | +14.6% |
| 2018 | Dec 31, 2018 | $63.76M | +68.0% |
| 2017 | Dec 29, 2017 | $37.95M | -27.8% |
| 2016 | Dec 30, 2016 | $52.60M | +36.8% |
| 2015 | Dec 31, 2015 | $38.44M | -99.4% |
| 2014 | Dec 31, 2014 | $6.71B | +2997.5% |
| 2013 | Dec 31, 2013 | $216.68M | -0.4% |
| 2012 | Dec 31, 2012 | $217.60M | -15.7% |
| 2011 | Dec 30, 2011 | $257.98M | -17.8% |
| 2010 | Dec 31, 2010 | $313.68M | – |
See a number that looks wrong?